BibTex format
@article{Gharbi:2015:10.1016/j.ijantimicag.2015.03.005,
author = {Gharbi, M and Moore, LSP and Gilchrist, M and Thomas, CP and Bamford, K and Brannigan, ET and Holmes, AH},
doi = {10.1016/j.ijantimicag.2015.03.005},
journal = {International Journal of Antimicrobial Agents},
pages = {150--156},
title = {Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit},
url = {http://dx.doi.org/10.1016/j.ijantimicag.2015.03.005},
volume = {46},
year = {2015}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - This study aimed to forecast the incidence rate of carbapenem resistance and to assess the impact of an antimicrobial stewardship intervention using routine antimicrobial consumption surveillance data. Following an outbreak of OXA-48-producing Klebsiella pneumoniae (January 2008–April 2010) in a renal cohort in London, a forecasting ARIMA model was derived using meropenem consumption data [defined daily dose per 100 occupied bed-days (DDD/100 OBD)] from 2005–2014 as a predictor of the incidence rate of OXA-48-producing organisms (number of new cases/year/100,000 OBD). Interrupted times series assessed the impact of meropenem consumption restriction as part of the outbreak control. Meropenem consumption at lag −1 year (the preceding year), highly correlated with the incidence of OXA-48-producing organisms (r = 0.71; P = 0.005), was included as a predictor within the forecasting model. The number of cases/100,000 OBD for 2014–2015 was estimated to be 4.96 (95% CI 2.53–7.39). Analysis of meropenem consumption pre- and post-intervention demonstrated an increase of 7.12 DDD/100 OBD/year (95% CI 2.97–11.27; P < 0.001) in the 4 years preceding the intervention, but a decrease thereafter. The change in slope was −9.11 DDD/100 OBD/year (95% CI −13.82 to −4.39). Analysis of alternative antimicrobials showed a significant increase in amikacin consumption post-intervention from 0.54 to 3.41 DDD/100 OBD/year (slope +0.72, 95% CI 0.29–1.15; P = 0.01). Total antimicrobials significantly decreased from 176.21 to 126.24 DDD/100 OBD/year (P = 0.05). Surveillance of routinely collected antimicrobial consumption data may provide a key warning indicator to anticipate increased incidence of carbapenem-resistant organisms. Further validation using real-time data is needed.
AU - Gharbi,M
AU - Moore,LSP
AU - Gilchrist,M
AU - Thomas,CP
AU - Bamford,K
AU - Brannigan,ET
AU - Holmes,AH
DO - 10.1016/j.ijantimicag.2015.03.005
EP - 156
PY - 2015///
SN - 1872-7913
SP - 150
TI - Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit
T2 - International Journal of Antimicrobial Agents
UR - http://dx.doi.org/10.1016/j.ijantimicag.2015.03.005
UR - http://hdl.handle.net/10044/1/39217
VL - 46
ER -
